Skip to main content
Log in

Hyperleptinemia: Implications on the Inflammatory State and Vascular Protection in Obese Adolescents Submitted to an Interdisciplinary Therapy

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The low-grade systemic inflammation seen in obesity may affect the actions of some adipose tissue-derived adipokines that are involved in the regulation of vascular function. We sought to verify whether hyperleptinemia may influence the inflammatory and atherogenic responses in obese adolescents undergoing interdisciplinary therapy. Thirty-four obese adolescents underwent interdisciplinary therapy for 1 year. Subjects were considered hyperleptinemic if they had baseline values of leptin above 20 ng/mL for boys and 24 ng/mL for girls. Both groups showed an improvement in body composition and a reduction in carotid intima-media thickness. However, only subjects in the non-hyperleptinemic group showed an increase in adiponectin concentration after therapy. Moreover, leptin concentration was positively correlated with adiponectin and inversely correlated with PAI-1 in this group. Hyperleptinemic state may impair the attenuation of inflammation in obese adolescents undergoing interdisciplinary therapy, particularly by impeding the increase in adiponectin concentration, which is directly involved in vascular protection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zhang, H., J. Cui, and C. Zhang. 2010. Emerging role of adipokines as mediators in atherosclerosis. World Journal of Cardiology 2(11): 370–376.

    Article  Google Scholar 

  2. Bełtowski, J. 2012. Leptin and the regulation of endothelial function in physiological and pathological conditions. Clinical and Experimental Pharmacology and Physiology 39(2): 168–178.

    Article  Google Scholar 

  3. Mantzoros, C.S., F. Magkos, M. Brinkoetter, E. Sienkiewicz, T.A. Dardeno, S.Y. Kim, O.P. Hamnvik, and A. Koniaris. 2011. Leptin in human physiology and pathophysiology. American Journal of Physiology, Endocrinology and Metabolism 301(4): E567–E584.

    Article  CAS  Google Scholar 

  4. Martin, S.S., A. Qasim, and M.P. Reilly. 2008. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 52(15): 1201–1210.

    Article  CAS  Google Scholar 

  5. Dâmaso, A.R., A. de Piano, P.L. Sanches, F. Corgosinho, L. Tock, L.M. Oyama, L. Tock, C.M. do Nascimento, S. Tufik, and M.T. de Mello. 2011. Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides 32(7): 1384–1391.

    Article  Google Scholar 

  6. González, M., Bibiloni M. Del Mar, A. Pons, I. Llompart, and J.A. Tur. 2012. Inflammatory markers and metabolic syndrome among adolescents. European Journal of Clinical Nutrition 66(10): 1141–1145.

    Article  Google Scholar 

  7. Matsuzawa, Y. 2005. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis Supplements 6(2): 7–14.

    Article  CAS  Google Scholar 

  8. Beauloye, V., F. Zech, H.T. Tran, P. Clapuyt, M. Maes, and S.M. Brichard. 2007. Determinants of early atherosclerosis in obese children and adolescents. Journal of Clinical Endocrinology and Metabolism 92: 3025–3032.

    Article  CAS  Google Scholar 

  9. Corgosinho, F.C., A. de Piano, P.L. Sanches, R.M. Campos, P.L. Silva, J. Carnier, L.M. Oyama, L. Tock, S. Tufik, M.T. de Mello, and A.R. Dâmaso. 2012. The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome. Inflammation 35(3): 944–951.

    Article  CAS  Google Scholar 

  10. de Lima, Sanches P., M.T. de Mello, N. Elias, F.A. Fonseca, A. de Piano, J. Carnier, L.M. Oyama, L. Tock, S. Tufik, and A.R. Dâmaso. 2011. Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program. Hypertension Research 34(2): 232–238.

    Article  Google Scholar 

  11. Korda, M., R. Kubant, S. Patton, and T. Malinski. 2008. Leptin-induced endothelial dysfunction in obesity. American Journal of Physiology-Heart and Circulatory Physiology 295(4): 1514–1521.

    Article  Google Scholar 

  12. Brennan, A.M., T.Y. Li, I. Kelesidis, A. Gavrila, F.B. Hu, and C.S. Mantzoros. 2007. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 50: 1178–1185.

    Article  CAS  Google Scholar 

  13. Matarese, G., C. Mantzoros, and A. La Cava. 2007. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Current Pharmaceutical Design 13: 3676–3680.

    Article  CAS  Google Scholar 

  14. Tanner, J.M., and R.H. Whitehouse. 1976. Clinical longitudinal standards for height, weight, weight velocity and stages of puberty. Archives of Disease in Childhood 51: 170–179.

    Article  CAS  Google Scholar 

  15. Centers for Disease Control and Prevention. Hyattsville: National Center for Health Statistics. (Updates on 11 January 2007; accessed on 15 August 2011). Prevalence ofoverweight among children and adolescents: United States 1999–2002. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm.

  16. Gutin, B., L. Ramsey, P. Barbeau, W. Cannady, M. Ferguson, M. Litaker, and S. Owens. 1999. Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training. American Journal of Clinical Nutrition 69: 388–394.

    Article  CAS  Google Scholar 

  17. de Piano, A., W.L. Prado, D.A. Caranti, K.O. Siqueira, S.G. Stella, M. Lofrano, L. Tock, D.M. Cristofalo, H. Lederman, S. Tufik, M.T. de Mello, and A.R. Dâmaso. 2007. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition 44: 446–452.

    Article  Google Scholar 

  18. Guardamagna, O., F. Abello, P. Saracco, V. Baracco, E. Rolfo, and M. Pirro. 2009. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 207: 471–475.

    Article  CAS  Google Scholar 

  19. Rabago Rodriguez, R., R.A. Gómez-Díaz, J. Tanus Haj, F.J. Avelar Garnica, E. Ramirez Soriano, E. Nishimura Meguro, C.A. Aguilar-Salinas, and N.H. Wacher. 2007. Carotid intima-media thickness in pediatric type 1 diabetic patients. Diabetes Care 30: 2599–2602.

    Article  Google Scholar 

  20. Friedewald, W., R. Levy, and D. Friderickson. 1972. Estimation of the concentration of low density protein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18: 449–515.

    Article  Google Scholar 

  21. Quijada, Z., M. Paoli, Y. Zerpa, N. Camacho, R. Cichetti, V. Villarroel, G. Arata-Bellabarba, and R. Lanes. 2008. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatric Diabetes 9: 464–471.

    Article  CAS  Google Scholar 

  22. Matsuhisa, M., Y. Yamasaki, M. Emoto, M. Shimabukuro, T. Funahashi, and Y. Matsuzawa. 2007. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Research and Clinical Practice 77: 151–154.

    Article  CAS  Google Scholar 

  23. Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr., E.J. Roccella, and National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. 2003. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 289(19): 2560–2572.

    Article  CAS  Google Scholar 

  24. Giuliano, I.C.B., B. Caramelli, L. Pellanda, B. Duncan, S. Mattos, and F.A.H. Fonseca. 2006. I Guideline for preventing atherosclerosis in childhood and adolescence. International Atherosclerosis 1: 1–30..

    Google Scholar 

  25. NRC. 2001. Dietary reference intake: applications in dietary assessment. Washington, DC: National Academic Press.

    Google Scholar 

  26. Donnelly, J.E., S.N. Blair, J.M. Jakicic, M.M. Manore, J.W. Rankin, and B.K. Smith. 2009. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Medicine & Science in Sports & Exercise 41: 459–471.

    Article  Google Scholar 

  27. Kelishadi, R., M. Hashemi, N. Mohammadifard, S. Asgary, and N. Khavarian. 2008. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clinical Chemistry 54(1): 147–153.

    Article  CAS  Google Scholar 

  28. Monzavi, R., D. Dreimane, M.E. Geffner, S. Braun, B. Conrad, M. Klier, and F.R. Kaufman. 2006. Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics 117: e1111–e1118.

    Article  Google Scholar 

  29. Matarese, G., S. Moschos, and C.H. Mantzoros. 2005. Leptin in immunology. Journal of Immunology 173: 3137–3142..

    Article  Google Scholar 

  30. Zhao, Y., R. Sun, L. You, C. Gao, and Z. Tian. 2003. Expression of leptin receptor and response to leptin stimulation of human natural killer cell lines. Biochemical and Biophysical Research Communications 300(2): 247–252.

    Article  CAS  Google Scholar 

  31. Li, F.Y., K.K. Cheng, K.S. Lam, P.M. Vanhoutte, and A. Xu. 2011. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiologica (Oxford, England) 203(1): 167–180.

    Article  CAS  Google Scholar 

  32. Ohashi, K., N. Ouchi, and Y. Matsuzawa. 2012. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 94(10): 2137–2142.

    Article  CAS  Google Scholar 

  33. Ouchi, N., and K. Walsh. 2007. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 380(1–2): 24–30.

    Article  CAS  Google Scholar 

  34. Norata, G.D., S. Raselli, L. Grigore, K. Garlaschelli, E. Dozio, P. Magni, and A.L. Catapano. 2007. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38: 2844–2846.

    Article  CAS  Google Scholar 

  35. Makni, E., W. Moalla, G. Lac, C. Aouichaoui, D. Cannon, M. Elloumi, and Z. Tabka. 2012. The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. Annales d’endocrinologie 73(1): 26–33..

    Article  CAS  Google Scholar 

  36. Dullaart, R.P., R. de Vries, A. Van Tol, and W.J. Sluiter. 2007. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. European Journal of Endocrinology 156: 387–394.

    Article  CAS  Google Scholar 

  37. Singh, P., T.E. Peterson, K.R. Barber, F.S. Kuniyoshi, A. Jensen, M. Hoffmann, A.S. Shamsuzzaman, and V.K. Somers. 2010. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochemical and Biophysical Research Communications 392(1): 47–52.

    Article  CAS  Google Scholar 

  38. Lijnen, H.R. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. Journal of Thrombosis and Haemostasis 3(1): 35–45.

    Article  CAS  Google Scholar 

  39. Scotece, M., J. Conde, R. Gómez, V. López, J. Pino, A. González, F. Lago, J.J. Gómez-Reino, and O. Gualillo. 2012. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators of Inflammation 125458.

Download references

Acknowledgments

We would like to thank the patients that participated of the study.

Grants

This study was supported in part by research grants from: AFIP; FAPESP 2008/53069-0; FAPESP 2011/50356-0, FAPESP 2011/50414-0; FAPESP (CEPID/Sleep #9814303-3 S.T); CNPq; CAPES (AUX-PE-PNPD 2566/2011); CEPE, FADA, and UNIFESP.

Disclosures

No conflicts of interest are reported by the author(s).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana R. Dâmaso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanches, P.L., de Mello, M.T., Elias, N. et al. Hyperleptinemia: Implications on the Inflammatory State and Vascular Protection in Obese Adolescents Submitted to an Interdisciplinary Therapy. Inflammation 37, 35–43 (2014). https://doi.org/10.1007/s10753-013-9709-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-013-9709-9

KEY WORDS

Navigation